David A. Fazzolare

WORK HISTORY

EDUCATION

ABOUT DAVID A. FAZZOLARE

I counsel clients in all areas of intellectual property including patents, trademarks, copyrights, and trade secrets, including over 15 years of experience advising clients, including startups, prominent university and research institutes, and Fortune 500 companies in the life sciences sector on the strategic development and management of their patent portfolios worldwide. I also advises clients on mitigating third party intellectual property risks throughout all phases of product development, including providing freedom to operate, non-infringement, and invalidity opinions, as well as performing due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities. I also have experience counseling on the Hatch-Waxman Act.With a background in pharmacology and biotechnology, and in-depth knowledge of regulatory affairs, I help clients maximize product lifecycles and revenue streams in the biotechnology, chemicals, materials sciences, medical devices, pharmaceuticals, and specialty chemicals areas. My diverse patent experience includes artificial cells and organs, bioassays, bioinformatics, biologics, cellular therapy and regenerative medicine, control systems, diagnostics, drug formulations and delivery systems, enzymes and microorganisms, gene editing, immunotherapy, industrial bioprocesses, nucleic acid synthesis and therapeutics, nutraceuticals, research tools, small molecules, stem cells & iPSCs, and vaccines.I provide cost-effective, practical, and business-focused solutions to my client’s complex legal problems. At Novozymes, I helped their first-generation biofuels business maintain their dominant market share by engaging in competitive patent drafting and prosecution with awareness of competitor’s products and using available USPTO procedures to challenge competitor filings, helping cross-functional product development teams to harvest inventions and work around competitor’s patents, counseling commercial teams on the negotiation and drafting of intellectual property provisions in partnering agreements, and collaborating with internal and external litigation teams on strategies for enforcing patents and defending against patent infringement lawsuits and IPRs. During law school, I worked for Myriad Genetics conducting prior art searching and patentability assessments, reviewing and drafting non-disclosure agreements, performing due diligence for acquisition and in-licensing of patent portfolios and devising strategies for staving off generic competition under the Hatch-Waxman Act.